EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanomaterial-Enhanced Corneal Cross-Linking: Engineering Strategies for Transforming Keratoconus Management

Liqin Huang iD, Yao Fu, Fang Li

Pharmaceutics · 25.06.2026 · 18 (7) · 778

DOI: 10.3390/pharmaceutics18070778 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 25.06.2026. Verfasst von Liqin Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. Die Arbeit nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Biomaterials and Regenerative Medicine Institute Cooperative Research Project, Shanghai Jiao Tong University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Keratoconus, a progressive corneal ectasia, remains a major cause of irreversible visual impairment worldwide. Conventional corneal cross-linking (CXL) with riboflavin/ultraviolet A (UVA) has revolutionized clinical management, yet its efficacy is still constrained by epithelial barriers, oxygen dependence, and safety concerns in thin corneas. Emerging nanotechnology provides a transformative opportunity to overcome these bottlenecks. This review highlights the enhancement of riboflavin delivery efficiency by nanocarriers, the photodynamic optimization of nano-enhanced cross-linking agents, and the synergistic strengthening effect of nanocomposites on corneal mechanical strength. We emphasize not only their potential to enhance drug penetration, improve cross-linking efficiency, and extend clinical indications, but also their role in advancing toward a new generation of personalized, intelligent, and minimally invasive corneal therapy. Finally, we discuss translational challenges, including manufacturing, long-term biosafety, and regulatory frameworks, and present a theoretical roadmap that integrates nanotechnology, real-time imaging, and artificial intelligence (AI)-assisted decision-making to achieve a closed-loop “sense–decide–act” therapeutic system. By situating nanomaterial-enhanced CXL within precision ophthalmology, this review highlights its capacity to redefine the standard of care for keratoconus and related ectatic disorders.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecorneal cross-linkingkeratoconusnanomaterialtheranosticstransepithelial

Autor:innen und Institutionen

  • Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
  • College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

ORCID-Profile: Liqin Huang

Förderung

  • National Natural Science Foundation of China
  • Biomaterials and Regenerative Medicine Institute Cooperative Research Project, Shanghai Jiao Tong University School of Medicine

Zitieren

APA

Huang, L., Fu, Y., & Li, F. (2026). Nanomaterial-Enhanced Corneal Cross-Linking: Engineering Strategies for Transforming Keratoconus Management. Pharmaceutics, 18(7), 778. https://doi.org/10.3390/pharmaceutics18070778

Vancouver

Huang L, Fu Y, Li F. Nanomaterial-Enhanced Corneal Cross-Linking: Engineering Strategies for Transforming Keratoconus Management. Pharmaceutics. 2026;18(7):778. doi:10.3390/pharmaceutics18070778

BibTeX
@article{Huang2026,
  author = {Huang, Liqin and Fu, Yao and Li, Fang},
  title = {Nanomaterial-Enhanced Corneal Cross-Linking: Engineering Strategies for Transforming Keratoconus Management},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {778},
  doi = {10.3390/pharmaceutics18070778}
}
Kostenlos starten →